72 articles

Cognitive Health & Aging

Peptide Biomarkers for Aging & Longevity

Plasma GHK-Cu declines from roughly 200 ng/mL at age 20 to 80 ng/mL by age 60—a pattern that has prompted researchers to examine peptide biomarkers in aging and whether shifts in circulating humanin and related peptides track longevity signaling pathways.

AdminUpdated Aug 1910 min

Peptide Mechanisms

Peptide Tachyphylaxis: Receptor Tolerance Guide

In 2004, cultured cell studies revealed that GLP-1 receptors desensitize within hours of continuous exposure—a finding that should have foreclosed their use as durable therapeutics, yet animal models and clinical trials told a different story about peptide tachyphylaxis and long-term receptor tolera

AdminUpdated Aug 1810 min

Peptide Mechanisms

Circulating Peptide Levels and Nutrition

In 2019, researchers began systematically measuring circulating peptide blood levels through LC-MS and related assays, revealing how nutritional intake correlates with serum peptide concentrations—a measurement challenge that has only recently moved beyond clinical endocrinology into broader researc

AdminUpdated Aug 1710 min

Peptide Mechanisms

Peptide Biased Signaling Selective Pathway Activation

Tirzepatide's approval in 2022 sparked quieter excitement among structural biologists studying peptide biased signaling—how a single receptor activates different cellular pathways depending on which molecule binds to it. The University of Michigan and Eli Lilly teams mapped the mechanism with unusua

AdminUpdated Aug 1410 min

Pharmacokinetics & Absorption

Retatrutide Pharmacokinetics and Tissue Distribution

Eli Lilly's 2023 Phase 2 trial data revealed how retatrutide's pharmacokinetics—specifically its absorption and extended half-life enabled by a fatty acid modification—allow weekly dosing despite targeting three hormone receptors simultaneously.

AdminUpdated Aug 139 min

Glucagon Receptor Signaling

Glucagon Receptor Agonist Metabolic Effects

In 1923, Canadian researchers identified glucagon as insulin's metabolic counterpart—a pancreatic hormone that raised blood sugar. A century later, glucagon receptor agonist research reveals the hormone's effects extend far beyond glucose regulation, influencing lipid metabolism, hepatic physiology,

AdminUpdated Aug 1210 min

NASH Fibrosis & Peptide Therapy

NASH Fibrosis Peptide Therapy Reversal

In March 2024, the FDA approved resmetirom for NASH, marking the first regulatory victory after two decades of failed Phase 3 trials—yet NASH fibrosis progression and peptide therapy's potential role in reversing scarring remain largely unexplored in clinical settings.

AdminUpdated Aug 119 min

Synthesis & Manufacturing

Peptide Solubility & Aggregation in Formulation

A single amino acid substitution transformed a reliable formulation into a cloudy suspension, revealing how peptide solubility aggregation and precipitation remain unpredictable even when protocols stay unchanged. The phenomenon—governed by charge distribution, pH buffering, and hydrophobic clusteri

AdminUpdated Aug 1010 min

Synthesis & Manufacturing

Peptide Drug Metabolism: Enzymatic Degradation Guide

In clinical pharmacology units worldwide, synthetic peptides face a fundamental barrier: the body's enzymes rapidly degrade them, often within minutes, a process called peptide drug metabolism that shapes which candidates advance to human trials and which never leave the animal-testing phase.

AdminUpdated Aug 710 min

Peptide Mechanisms

GHRH vs GHRP: Growth Hormone Pathways

In 1982, researchers isolated growth hormone-releasing hormone—one of two fundamentally different molecular pathways through which the pituitary secretes growth hormone. The discovery of GHRH's structural cousin, GHRP, revealed that the body routes this signal through mechanisms that remain incomple

AdminUpdated Aug 79 min

Peptide Mechanisms

Peptide Immunogenicity in Immune Response

In 2023, the FDA flagged three peptides as substances warranting caution, citing immunogenicity risk among concerns for compounds that had never undergone formal clinical safety assessment—an acknowledgment that peptide immunogenicity and immune response dynamics remain poorly understood outside con

AdminUpdated Aug 510 min

Synthesis & Manufacturing

Peptide PTM: Phosphorylation & Glycosylation

When Frederick Banting's team discovered insulin in 1921, they faced an unexpected obstacle: the hormone degraded within hours, requiring multiple injections daily. Today, peptide post-translational modifications like phosphorylation and glycosylation offer a solution to this ancient stability probl

AdminUpdated Aug 410 min